ClinicalTrials.gg
Not yet recruitingNCT07892846Updated Oct 23, 2026

The Intervention Effect of Exercise on Lumbar Multifidus Muscle Injuries

An interventional study of Lumbar multifidus muscle rehabilitation exercise in Chronic Non-specific Low Back Pain With Lumbar Multifidus Muscle Injury or Dysfunction, sponsored by Chinese PLA General Hospital. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Chinese PLA General Hospital · Not applicable, Interventional, and Other

Updated Oct 23, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This is a single-center, prospective interventional study. The main purpose is to use ultrasound radiomics to analyze changes in multifidus muscle ultrasound imaging features before and after rehabilitation therapy in patients with low back pain related to lumbar multifidus injury, and explore whether these imaging features can be used to evaluate treatment response.

Eligible participants are aged 18-80 years with chronic non-specific low back pain lasting more than 3 months, NRS/VAS pain score ≥1, and abnormal baseline ultrasound findings of the lumbar multifidus muscle. All participants will receive a 12-week home-based rehabilitation program, including prone multifidus activation exercises and core stability training, 3-5 times per week, 20-30 minutes each session.

The primary outcome measures are changes in multifidus muscle area, ultrasound imaging features and pain scores after training. Safety will be monitored throughout the study. Training will be adjusted or paused if participants have increased pain, new radiating leg symptoms, dizziness, chest tightness, palpitations, or other adverse conditions.

Read the detailed description

Background: Chronic non-specific low back pain is common, and lumbar multifidus injury or dysfunction is closely associated with this condition. Ultrasound imaging can visualize the morphological features of the multifidus muscle. Radiomics analysis may extract quantitative imaging biomarkers to objectively assess muscle changes after rehabilitation. This study aims to investigate the feasibility of ultrasound radiomics for evaluating rehabilitation treatment effects.

Methods: This is a prospective, single-center interventional trial. Patients aged 18-80 years diagnosed with chronic non-specific low back pain (≥3 months) with NRS/VAS ≥1 and abnormal multifidus ultrasound findings will be enrolled. Subjects will perform 12 weeks of home rehabilitation training: prone multifidus local activation and core stability exercises, 3-5 times weekly, 20-30 minutes per session.

Primary endpoints include changes in multifidus muscle area, ultrasound radiomic features and pain scores after intervention. Secondary objective is to analyze correlations between changes in multifidus ultrasound parameters and improvements in pain and physical function.

Safety monitoring: Training will be modified or suspended if pain increases by ≥2 points compared with baseline and persists, new or worsening radiating pain, numbness or weakness in lower extremities occurs, or participants develop obvious dizziness, chest tightness or palpitations. Investigators will assess risks and decide whether to continue training. All adverse events will be recorded and evaluated.

02

Conditions studied

  • Chronic Non-specific Low Back Pain With Lumbar Multifidus Muscle Injury or Dysfunction

Browse trials for

Keywords

  • Low back pain
  • Lumbar multifidus muscle
  • Rehabilitation exercise
  • Ultrasound radiomics
  • Muscle injury
03

In context

Low Back Pain

2,875 studies on the registry are indexed under Low Back Pain; 484 are open to participants now.

This study's planned enrollment of 40 is below the median of 60 across 2,315 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

Chinese PLA General Hospital is the lead sponsor of 568 studies on the registry; 205 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Aged 18-80 years old, no restriction on gender.
  2. Diagnosed with non-specific low back pain with disease duration ≥ 3 months.
  3. Numerical Rating Scale (NRS) / Visual Analog Scale (VAS) pain score ≥ 1 point.
  4. Clinically suspected lumbar multifidus muscle injury or dysfunction, with at least one abnormal finding of lumbar multifidus muscle on baseline ultrasound examination, including reduced resting thickness, left-right asymmetry, decreased cross-sectional area or increased echogenicity.
  5. Able to understand the research content and voluntarily sign the informed consent form.
  6. Able to cooperate to complete rehabilitation training and follow-up assessments.

Exclusion criteria

Exclusion Criteria:

  1. Presence of specific causes of low back pain, such as lumbar infection, tumor, fracture, inflammatory spondyloarthropathy, etc.
  2. Obvious nerve root compression symptoms, cauda equina syndrome or progressive neurological deficits.
  3. Previous history of lumbar spine surgery.
  4. Severe lumbar spondylolisthesis, severe spinal stenosis, severe osteoporosis or other conditions unsuitable for rehabilitation training.
  5. Complicated with severe cardiopulmonary disease, malignant tumor, systemic infection or other diseases intolerant to training.
  6. Pregnant or lactating women.
  7. Received systematic lumbar back rehabilitation training, local block/injection therapy or other interventions that may affect outcome assessment within the past 4 weeks.
  8. Combined with severe mental disorders, cognitive impairment or poor compliance, unable to cooperate with the study.
  9. Patients with long-term use of hormones or analgesic medications.
  10. Other conditions judged by the investigator to be inappropriate for enrollment.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Rehabilitation Exercise Intervention Arm

    Participants receive a 12-week home-based rehabilitation exercise program targeting lumbar multifidus muscle. Baseline and post-intervention ultrasound examination, ultrasound radiomics analysis and pain function assessment will be performed.

    Behavioral: Lumbar multifidus muscle rehabilitation exercise

Interventions

  • BehavioralLumbar multifidus muscle rehabilitation exercise

    12-week home-based targeted rehabilitation exercise program for lumbar multifidus muscle. Participants complete prescribed exercise at home following guidance.

06

What researchers measure

Primary outcomes

  1. Change in cross-sectional area of lumbar multifidus muscle measured by ultrasound

    The cross-sectional area of lumbar multifidus muscle will be measured by B-mode ultrasound. The difference between baseline and post-intervention value will be calculated to evaluate the morphological change of lumbar multifidus muscle after 12-week rehabilitation exercise.

    Time frame: Baseline and 12 weeks after intervention

Secondary outcomes

  1. Change in Visual Analog Scale (VAS) pain score

    Visual Analog Scale (VAS, 0-10 points) will be used to assess low back pain intensity. Higher score indicates more severe pain. Change from baseline will be evaluated after 12 weeks of exercise intervention.

    Time frame: Baseline and 12 weeks after intervention

  2. Change in Oswestry Disability Index (ODI)

    Oswestry Disability Index (0-100%) will be applied to evaluate functional disability caused by low back pain. Higher percentage represents greater functional impairment. The change from baseline will be assessed at 12 weeks.

    Time frame: Baseline and 12 weeks after intervention

  3. Change in ultrasound radiomics features of lumbar multifidus muscle

    Quantitative radiomics features (texture, histogram features) extracted from lumbar multifidus ultrasound images will be analyzed to reflect muscle tissue characteristics before and after 12-week rehabilitation training.

    Time frame: Baseline and 12 weeks after intervention

07

Study locations

1 site
  • Chinese PLA General Hospital
    Beijing, Beijing Municipality, China
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared publicly due to patient privacy protection and institutional data management requirements.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for May 2027, 7 months later.

Of 1,187 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 7 months is below that.

Counting every sponsor, half of 1,246 studies reached it within 11 months; a quarter within 5 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 18, 2026
First posted
Oct 23, 2026
StartEst.
Oct 2026
Primary completionEst.
May 2027
CompletionEst.
May 2027
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07892846
Responsible party
Mingbo Zhang (Associate Chief Physician, Department of Ultrasound, Chinese PLA General Hospital) — Principal investigator
First posted
Oct 23, 2026
Start date
Oct 2026 (estimated)
Primary completion
May 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Oct 23, 2026

Study contacts

Mingbo Zhang, MD
Contact
owsifanduizhe@126.com
+8613552744805
Mingbo Zhang, MD
principal investigator · Chinese PLA General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion